individualized, tumor-identifying therapeutics (Affigen)

N/A

Report date: 2025/01/26 19:13:56
NME

Base Information

Drug Nameindividualized, tumor-identifying therapeutics (Affigen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, B-CellLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffigen Llc
China Registration ClassN/A

Develop Information

Active CompaniesAffigen Llc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-CellLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A